Ozempic
Ozempic (semaglutide) is a once-weekly injectable medication approved for managing type 2 diabetes, reducing major cardiovascular risks, and aiding weight management by regulating appetite.
Mounjaro
Mounjaro (tirzepatide) is a once-weekly, subcutaneous injection approved for treating type 2 diabetes and chronic weight management in adults with obesity or overweight
Retatrutide
Retatrutide is a once-weekly injectable triple-hormone receptor agonist (GIP, GLP-1, and glucagon) developed by Eli Lilly for obesity and type 2 diabetes management.
1
/
of
3
Featured collection
-
Retatrutide
Regular price R 2,999.00Regular priceSale price R 2,999.00 -
Ozempic(semaglutide)
Regular price R 2,999.00Regular priceSale price R 2,999.00
Blog posts
-
Retatrutide vs Mounjaro
CLICK HERE
Retatrutide vs Mounjaro
CLICK HERE
-
Ozempic vs Mounjaro vs Retatrutide
CLICK HERE
Ozempic vs Mounjaro vs Retatrutide
CLICK HERE
-
Ozempic vs Mounjaro vs Retatrutide
WHICH ONE IS THE BEST? Click Highlight
Ozempic vs Mounjaro vs Retatrutide
WHICH ONE IS THE BEST? Click Highlight
1
/
of
3